• 1. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 2. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 3. Enantiomorphic symmetry breaking in crystallization of molten sodium chlorate?
  Martin R. Ward,Gary W. Copeland,Andrew J. Alexander Chem. Commun., 2010,46, 7634-7636
• 4. Estimation of hydrogen sulfide from crude petroleum: a unique invention using a simple chemosensor?
  Shampa Kundu,Prithidipa Sahoo New J. Chem., 2019,43, 12369-12374
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

Comprehensive Overview of 3,5,5-Trimethylpiperidin-2-one (CAS No. 1461709-34-1): Properties, Applications, and Industry Insights

3,5,5-Trimethylpiperidin-2-one (CAS No. 1461709-34-1) is a specialized organic compound belonging to the piperidinone family. This heterocyclic molecule features a six-membered ring with a ketone functional group, making it a versatile intermediate in pharmaceutical and agrochemical synthesis. The compound's unique steric hindrance due to its three methyl groups at positions 3, 5, and 5 contributes to its distinct reactivity profile, attracting significant interest from researchers exploring chiral synthesis and bioactive molecule design.

Recent advancements in drug discovery have highlighted the importance of 3,5,5-trimethylpiperidin-2-one as a building block for CNS-targeting compounds. Its structural similarity to neurotransmitter modulators positions it as a valuable scaffold for developing treatments targeting neurological disorders—a trending topic in precision medicine forums. Analytical techniques like HPLC-MS and NMR spectroscopy confirm its high purity (>98%), meeting stringent requirements for GMP-compliant synthesis in clinical trials.

The compound's thermal stability (decomposition point >200°C) and moderate solubility in polar aprotic solvents make it suitable for continuous flow chemistry applications—an increasingly popular green chemistry approach that reduces waste generation. Industry reports indicate growing demand for 1461709-34-1 in electronic materials manufacturing, where its derivatives contribute to advanced polymer stabilizers and OLED intermediates.

Environmental considerations surrounding 3,5,5-trimethylpiperidin-2-one have prompted studies on its biodegradation pathways, aligning with the sustainable chemistry movement. Computational modeling suggests potential applications in CO2 capture materials, addressing climate change mitigation strategies—a hot topic in material science research. The compound's structure-activity relationships are frequently discussed in QSAR studies for optimizing drug-like properties.

Quality control protocols for CAS 1461709-34-1 emphasize genotoxic impurity monitoring, reflecting pharmaceutical industry concerns about ICH M7 guidelines compliance. Analytical method development for this compound often involves UHPLC-UV systems with QbD principles, ensuring robust quantification in complex matrices. Recent patent filings reveal innovative uses in photoresist formulations for semiconductor manufacturing, connecting to the booming chip technology sector.

Supply chain analytics show increasing 3,5,5-trimethylpiperidin-2-one procurement by contract research organizations (CROs), particularly for proteolysis-targeting chimera (PROTAC) development. The compound's hydrogen bonding capacity and lipophilicity (calculated logP ~1.2) make it valuable for designing protein degraders—a cutting-edge area in oncological research. Storage recommendations typically specify nitrogen atmosphere protection to maintain stability during long-term storage.

Emerging applications in flavor and fragrance chemistry leverage the compound's masked carbonyl characteristics for controlled release systems. Regulatory status reviews confirm REACH compliance for 1461709-34-1 in European markets, while FDA DMF filings indicate pharmaceutical interest. Process chemistry innovations have developed atom-economical routes for its synthesis, reducing byproduct formation through catalytic hydrogenation techniques.

The scientific literature documents 3,5,5-trimethylpiperidin-2-one's role in creating ionic liquid precursors for battery electrolytes, connecting to renewable energy storage solutions. Its vapor pressure characteristics (measured at 25°C) inform safety assessments for industrial scale-up. Academic collaborations are exploring its potential in asymmetric catalysis, particularly for constructing quaternary carbon centers—a persistent challenge in total synthesis projects.

Market intelligence reports project compound growth in the fine chemicals sector, driven by demand for high-value intermediates in bioconjugation technologies. Technical data sheets emphasize proper ventilation requirements when handling powdered forms, following OSHA standards for laboratory safety. Recent structure elucidation studies using X-ray crystallography have confirmed its boat conformation in solid state, providing insights for molecular docking simulations.

Innovative purification methods employing simulated moving bed chromatography have improved 1461709-34-1 production efficiency, reducing solvent consumption by 40% compared to traditional methods. The compound's compatibility with microwave-assisted synthesis has enabled rapid library generation for medicinal chemistry screening. Environmental fate studies demonstrate readily biodegradable characteristics under OECD 301 test conditions, supporting its green chemistry credentials.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)